Resveratrol attenuates advanced glycation end product-induced senescence and inflammation in human gingival fibroblasts

被引:4
|
作者
Huang, Chao -Yen [1 ,2 ,3 ]
Chen, Szu-Han [1 ,4 ]
Lin, Taichen [4 ,5 ]
Liao, Yi-Wen [1 ,6 ]
Chang, Yu-Cheng [7 ]
Chen, Chun-Cheng [4 ,5 ]
Yu, Cheng-Chia [1 ,4 ,5 ]
Chen, Chun -Jung [8 ]
机构
[1] Chung Shan Med Univ, Inst Oral Sci, 110,Sec 1,Jianguo N Rd, Taichung 40201, Taiwan
[2] Chung Shan Med Univ Hosp, Dept Emergency Med, Taichung, Taiwan
[3] Chung Shan Med Univ, Sch Med, Taichung, Taiwan
[4] Chung Shan Med Univ, Sch Dent, Taichung, Taiwan
[5] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan
[6] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan
[7] Univ Penn, Sch Dent Med, Dept Periodont, Philadelphia, PA USA
[8] Chi Mei Med Ctr, Dept Dent, Div Periodont, 901 Zhonghua Rd, Tainan 71004, Taiwan
关键词
Advanced glycation end products; Inflammaging; Senescence; Diabetic periodontitis; Resveratrol; CELLULAR SENESCENCE; PERIODONTITIS; MICE;
D O I
10.1016/j.jds.2023.10.016
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background/purpose: The accumulation of advanced glycation end products (AGEs) lead to a series of immune responses such as: increased oxidative stress and inflammation which contribute to the development of diabetic complications and periodontal disease. Resveratrol is a natural compound that has anti-oxidant and anti-inflammatory effects. Studies have found that diabetes-induced periodontitis is mainly caused by oxidative stress, aging and increased inflammation. In view of resveratrol has been proposed to have the ability in anti-oxidant and anti-inflammation in a variety of tissues. However, the role of resveratrol in diabetic periodontitis remains to be investigated. In this study, we aimed to investigate the role of resveratrol in preventing and treating diabetic periodontitis. Materials and methods: First, cell proliferation was measured in AGEs-treated human gingival fibroblast with or without resveratrol. We examined the reactive oxygen species (ROS) generation, senescence-associated beta-galactosidase (SA-b-gal) and senescence marker p16 in human gingival fibroblasts (HGFs) stimulated with AGEs with or without the treatment of resveratrol. To determine whether resveratrol has the potential to regulate inflammaging which is mediated via the NF-kB signaling pathway and, the expression of p65 and p-IkB were also investigated. Furthermore, the concentration of interleukin (IL)-6 and IL-8 were also measured in AGEs-stimulated HGFs treated with or without resveratrol. Results: ROS generation, cell senescence, and the secretion of IL-6 and IL-8 were significantly upregulated following the treatment of AGEs. However, the administration of resveratrol suppresses the generation of IL-6 and IL-8 and cell senescence via inhibiting NF-kB signaling pathway. Our results revealed that resveratrol inhibits inflammaging by downregulating NFConclusion: According to our findings, AGEs increase senescence and the production of proinflammatory cytokines in the gingiva, while the administration of resveratrol impedes inflam 2023 Association for Dental Sciences of the Republic of China. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
引用
收藏
页码:580 / 586
页数:7
相关论文
共 50 条
  • [31] SIRT6 alleviates senescence induced by Porphyromonas gingivalis in human gingival fibroblasts
    Shi, Jia
    Hao, Xin-yu
    Tong, Yue
    Qian, Wen-bo
    Sun, Ying
    MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
  • [32] Pioglitazone Inhibits Advanced Glycation End Product-Induced TNF-α and MMP-13 Expression via the Antagonism of NF-κB Activation in Chondrocytes
    Chen, Cheng
    Ma, Chi
    Zhang, Ying
    Zeng, Yuelin
    Li, Yuqing
    Wang, Wanchun
    PHARMACOLOGY, 2014, 94 (5-6) : 265 - 272
  • [33] Inhibitory effect of resveratrol on advanced glycation end products-induced mesangial cell proliferation
    Jiang, Bei
    Li, Baoying
    Guo, Ling
    Song, Jian
    Li, Xianhua
    Yang, Xiangdong
    Hu, Zhao
    Gao, Haiqing
    AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY, 2012, 6 (10): : 737 - 742
  • [35] Exploring the protective effects of Spinosin against advanced glycation end product-induced cellular damage through modulation RAGE/MAPK/ NF-κB pathway
    Li, Wei
    Zhang, Yanqing
    Tian, Na
    Xie, Junbo
    FOOD BIOSCIENCE, 2025, 64
  • [36] Advanced Glycation End Product Inhibitor Pyridoxamine Attenuates IVD Degeneration in Type 2 Diabetic Rats
    Glaeser, Juliane D.
    Ju, Derek
    Tawackoli, Wafa
    Yang, Jae H.
    Salehi, Khosrowdad
    Stefanovic, Tina
    Kanim, Linda E. A.
    Avalos, Pablo
    Kaneda, Giselle
    Stephan, Stephen
    Metzger, Melodie F.
    Bae, Hyun W.
    Sheyn, Dmitriy
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (24) : 1 - 15
  • [37] Differential contribution of possible pattern-recognition receptors to advanced glycation end product-induced cellular responses in macrophage-like RAW264.7 cells
    Watanabe, Masahiro
    Toyomura, Takao
    Wake, Hidenori
    Liu, Keyue
    Teshigawara, Kiyoshi
    Takahashi, Hideo
    Nishibori, Masahiro
    Mori, Shuji
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2020, 67 (02) : 265 - 272
  • [38] Blockade of the receptor for advanced glycation end products attenuates acetaminophen-induced hepatotoxicity in mice
    Ekong, U
    Zeng, S
    Dun, H
    Feirt, N
    Guo, JC
    Ippagunta, N
    Guarrera, JV
    Lu, Y
    Weinberg, A
    Qu, W
    Ramasamy, R
    Schmidt, AM
    Emond, JC
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (04) : 682 - 688
  • [39] 6-Shogaol Inhibits Advanced Glycation End-Products-Induced IL-6 and ICAM-1 Expression by Regulating Oxidative Responses in Human Gingival Fibroblasts
    Nonaka, Kohei
    Bando, Mika
    Sakamoto, Eijiro
    Inagaki, Yuji
    Naruishi, Koji
    Yumoto, Hiromichi
    Kido, Jun-ichi
    MOLECULES, 2019, 24 (20):
  • [40] Resveratrol Alleviates Advanced Glycation End-Products-Related Renal Dysfunction in D-Galactose-Induced Aging Mice
    Lan, Kuo-Cheng
    Peng, Pei-Jin
    Chang, Ting-Yu
    Liu, Shing-Hwa
    METABOLITES, 2023, 13 (05)